Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2014:2014:459192.
doi: 10.1155/2014/459192. Epub 2014 Nov 12.

Factor XII (Hageman) levels in women with recurrent pregnancy loss

A Seval Ozgu-Erdinc  1 , Cihan Togrul  2 , Ayla Aktulay  1 , Umran Buyukkagnici  3 , Elif Gul Yapar Eyi  1 , Salim Erkaya  1
Affiliations
Observational Study

Factor XII (Hageman) levels in women with recurrent pregnancy loss

A Seval Ozgu-Erdinc et al. J Pregnancy. 2014.

Abstract

Objective: To evaluate factor XII levels in women with recurrent pregnancy loss (RPL) in a tertiary referral hospital.

Methods: Women who were referred to our hospital for two consecutive abortions or three abortions in between 2007 and 2013 were included in this retrospective observational study. Women were further grouped according to factor XII levels, as <60% and ≥ 60%.

Results: Mean factor XII level was 109.1 ± 35.7% (range: 9-200). Ninety-three (7.4%) women had factor XII levels < 60%. Mean factor XII level was 44.8 ± 13.1, and levels ranged between 9 and 60 in this group. Only one woman had factor XII level < 10 %. Remaining 1164 (92.6%) women had factor XII levels ≥ 60%. Mean factor XII level was 114.3 ± 31.7, and levels ranged between 60.3 and 200 in this group, while 1015 (72.4%) women had factor XII levels within the normal range (60%-150% [100% = 30 μg/mL]).

Conclusion: Decreased activity of F-XII was diagnosed in 7.4% of women with RPL. We concluded factor XII deficiency that might be a rare but significant factor for RPL, and should be evaluated in women who are investigated for recurrent pregnancy loss.

PubMed Disclaimer

References

    1. Sugi T. Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses. Journal of Obstetrics and Gynaecology Research. 2013;39(7):1223–1229. doi: 10.1111/jog.12110. - DOI - PubMed
    1. Inomo A., Sugi T., Fujita Y., Matsubayashi H., Izumi S.-I., Mikami M. The antigenic binding sites of autoantibodies to factor XII in patients with recurrent pregnancy losses. Thrombosis & Haemostasis. 2008;99(2):316–323. doi: 10.1160/TH07-07-0447. - DOI - PubMed
    1. Pauer H.-U., Burfeind P., Köstering H., Emons G., Hinney B. Factor XII deficiency is strongly associated with primary recurrent abortions. Fertility and Sterility. 2003;80(3):590–594. doi: 10.1016/S0015-0282(03)00788-X. - DOI - PubMed
    1. Jones D. W., Gallimore M. J., Winter M. Antibodies to factor XII: a possible predictive marker for recurrent foetal loss. Immunobiology. 2003;207(1):43–46. doi: 10.1078/0171-2985-00207. - DOI - PubMed
    1. Sotiriadis A., Makrigiannakis A., Stefos T., Paraskevaidis E., Kalantaridou S. N. Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis. Obstetrics and Gynecology. 2007;109(5):1146–1155. doi: 10.1097/01.AOG.0000260873.94196.d6. - DOI - PubMed

Publication types

LinkOut - more resources